/* */ PELVIPHARM - SPECIALIZED PRECLINICAL EXPERTISE in male and female sexual functions and diseases of the lower urinary tract
Receive our news


December 18th - 2018

Best Wishes 2019


October 11th - 2018

Recently accepted paper in J Sex Med

The Favorable Effect of Empagliflozin on Erectile Function in an Experimental Model of Type 2 Diabetes.

Assaly R, Gorny D, Compagnie S, Mayoux E, Bernabe J, Alexandre L, Giuliano F, Behr-Roussel D.

J Sex Med, 2018 Sep;15(9):1224-1234

March 7th - 2018

Future presentation at the EAU 2018

Pelvipharm at the EAU (European Association of Urology) in Copenhagen, Denmark, 16-20 March 2018 .

Pelvipharm will present one abstract during the podium session entitled "Future and new approaches in the treatment of male sexual dysfunction":

  • "Low intensity-shockwave therapy (Li-ESWT) delivered by Aries® improves erectile function and decreases cavernosal fibrosis of spontaneously hypertensive rats (SHR)"
    Giuliano F., Assaly-Kaddoum R., Laurin M., Bernabé J., Behr-Roussel D.

The poster session 72 will take place in "Blue Area, Room 5 (Level 0) on Monday 19 march 2018.

 Please come and see us, we will be happy to discuss our results with you and potential applications for you. 


June 11th - 2018

Bio 2Business in Basel, June 2018

Pelvipharm will be represented by Rana Assaly at the next BIO 2Business meeting in Basel, June 19-20 2018.
We warmly invite you to take this opportunity to learn more about our services.

If you’d like to set up a specific meeting at any time throughout the conference, please email contact@pelvipharm.com and we will be happy to assist you.


January 4th - 2018

Best Wishes 2018


TEL +331 704 293 39
FAX + 331 704 295 10